Interesting session! with this super smart guy Ben Ponvilawan, MD, MS live now at 33ABC San Diego Convention Center! Navigating Rapid Changes in First- and Later-Line Treatment of EGFR-Mutated NSCLC 🧬🩻💉 Best wish for our #hemonc #match2025 IASLC #WCLC24

🔥🚨OncoAlert HOT OFF THE PRESS. Just presented at the presidential symposium IASLC #WCLC24 Results of #HARMONi2 trial of #Ivonescimab VS #Pembrolizumab in advanced non-small cell #LungCancer with PD-L1 >1%. ✅ Significant ⬆️mPFS 11.14 vs. 5.82 months (HR 0.51) #Benefit

With the goal of addressing a key clinical question, which pts w lung cancer may benefit from adjuvant immunotherapy after neoadjuvant, today at #WCLC2024 we presented results of an exploratory individual pt level analysis of the #CM77T & #CM816 trials 1/

🥳 Congratulations! Kanishka Uttam Chandani for 2 posters here! And Ben Ponvilawan, MD, MS for mini oral presentation Such a strong work! We will do great in matching this year! 🩺🪬 H.O.M.E Hem-Onc Fellows Network IASLC #WCLC24

Proudly presenting my e-poster research at #WCLC24 Excited to share insights and contribute to the conversation! EP.11A.29 C-Reactive Protein's Impact on Immune Adverse Events in Non Small Cell Lung Cancer Patients Undergoing Immunotherapy: Meta-Analysis IASLC H.O.M.E

Successful Hemeonc #Match2025 fellowship applicants meet up led by Tulsi Jose, MD at the #WCLC24 conference, San Diego. Future of #hemeonc is bright with PDs like Rami Manochakian MD, FASCO Cancer Education advocating for Diversity, Equity & Inclusivity. Abhinav Vyas, MD Sawyer Bawek, DO Sakditad “Tew” Saowapa, MD Ben Ponvilawan, MD, MS

Happy to present a mini oral presentation about identifying patient population that may benefit more from double ICI regimen compared to those with single ICI. Thank you for the gracious support and mentorship from @dhruvsxu Janakiraman Subramanian #WCLC24 H.O.M.E IASLC

New ⁦National Comprehensive Cancer Network (NCCN)⁩ guidelines for Breast/Ovarian/Pancreatic Cancer Genetics posted at nccn.org/professionals/… New recommendation that #PancreaticCancer screening be “considered” for all BRCA2 and ATM pathogenic variant carriers by age 50, even without known family history

This is a nice summary of the mechanisms of action of various KRAS inhibitors from Adrienne Cox & Channing Der in their Science Magazine perspective.

🔥🚨1/2 Hot off the press. Just published JCO Oncology Practice #Guide to Understanding & Supporting #International #MedicalGraduates in #Hematology/#Oncology by ASCO #IMGs Community of Practice. I’m honored to be part of this work with GREAT COLLEAGUES. 👇🏼 tinyurl.com/2su6r8zx

Our correspondence is now available on The Lancet! Differences in HCC etiology may contribute to the positive result of camrelizumab plus rivoceranib in CARES-310 trial, in contrast to other IO+TKI trials. Thank you Marc Roth Saint Luke's Cancer Institute for the support. thelancet.com/journals/lance…

Deeply honored to become a Heme/Onc fellow at Northwestern Medicine starting next July! Super grateful to my family, friends, mentors, UMKC Internal Medicine Residency Program, and everyone who has supported me throughout the long journey. Northwestern Hematology/Oncology Fellowship H.O.M.E #Match2025 #HemeOnc

Excited to celebrate the outstanding fellowship match results of our UMKC Internal Medicine residents! We’re proud of your achievements and look forward to your continued success in the next chapter of your careers. #UMKCIM #FellowshipMatch2024

Our paper recently published in JAMA Network Open Doublet IO might be more beneficial in patients with pd-l1 negative squamous cell lung cancer jamanetwork.com/journals/jaman…

🎤 Excited to present at the #NCCN2025 Conference! National Comprehensive Cancer Network (NCCN) 📊 Racial Disparities in NSCLC Survival Outcomes: A Systematic Review & Meta-Analysis ✅ Asian/API patients had significantly better OS vs. White patients ❌ No significant differences in OS for Black or Hispanic patients

We encourage you to check out our article on tips for finding a HemeOnc job in the U.S. while on a J1 visa. It offers practical advice from individuals who have navigated the same process! ASCO #ASCOConnections Rohit Singh, MD

🚨Save the date🚨 ASCO #IMG Community of Practice Meeting at #ASCO25 ⏰May 30st, 4-6 PM CST 📌Room S103, McCormick Place Join us to discuss barriers & opportunities for IMGs ASCO IMG CoP👉bit.ly/3JmJQwK The ASCO Post #IMGoncCoP #MedEd #MedTwitter

🤩Honored to be a co-author on this important work led by our incredible attending Dr. Arya Arya Roy, spotlighting the academic productivity of IMG fellows. Grateful for the opportunity to contribute!🙌 📅 Oral Presentation: 6/2/2025 | 9:45–9:51 AM 🔗 meetings.asco.org/abstracts-pres…

#ASCO25 Day 2: so proud of our two stellar residents, soon to be fellows! Himil Mahadevia, MBBS (Himil Mahadevia) and Parth Sharma. Congrats on the posters, can’t wait to see what your futures hold! Saint Luke's Cancer Institute Saint Luke's

#ASCO2025